Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular Steroid for Unexplained Chronic Cough
NCT06634823Phase 1Recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2024
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of triamcinolone in unexplained chronic cough (2 arms), sponsored by Medical University of South Carolina. Primary endpoint: Leicester Cough Questionnaire at 4 weeks. Started Dec 2024; status: recruiting.
02
Drugs
triamcinolone
03
Conditions
unexplained chronic cough
Beyond the preview
Go deeper on NCT06634823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06634823.